Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home
For questions about DPDx, contact us
DPDx

DPDx is an education resource designed for health professionals and laboratory scientists.

Acanthocephaliasis

[Bolbosoma spp.] [Macracanthorhynchus hirudinaceous] [Moniliformis moniliformis]

Treatment Information

Few human cases of acanthocephaliasis have been reported, most of which have been caused by the parasitic worm Moniliformis moniliformis. Some experts consider pyrantel pamoate* the treatment of choice to expel the worm from the body. The treatment regimen consists of a total of 3 oral doses of pyrantel pamoate (11 mg/kg per dose) separated by 2-week intervals.

Back to Top


This information is provided as an informational resource for licensed health care providers as guidance only. It is not intended as a substitute for professional judgment.

 
For questions about DPDx, contact us
  • Page last reviewed November 29, 2013
  • Page last updated November 29, 2013
  • Content source: Global Health - Division of Parasitic Diseases and Malaria
  • Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO